API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
  • API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-Sung Enoxacin
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Product Name
Enoxacin
Name
Enoxacin Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
74011-58-8
Mf
C15h17fn4o3
Logp
1.05710
Psa
87.46000
Boiling Point
569.9ºC at 760 Mmhg
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
Product Description
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials EnoxacinAPI CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
Product Details
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
 
Product name enoxacin
Appearance White powder
Cas number 74011-58-8
MF C15H17FN4O3
Enoxacin is a broad-spectrum quinolone antibiotic developed by Dainippon Pharmaceutical Co., LTD. It was first approved for marketing in Japan in 1986. It causes bacterial death by acting on the A subunit of bacterial DNA helicase, which inhibits DNA synthesis and replication. This product has a broad spectrum antibacterial action, especially against aerobic gram-negative bacilli with high antibacterial activity, and has a good antibacterial action against the following bacteria in vitro: most bacteria of the Enterobacteriaceae, including citrobacter, Clostridium, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Often has the antibacterial activity Chemicalbook to multi - drug - resistant bacteria. The penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella all had high antibacterial activity. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, but only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic streptococcus and Enterococcus faecalis. It has good antimicrobial action against Chlamydia trachomatis, Mycoplasma and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and Mycobacterium atypical. Poor antibacterial activity against anaerobic bacteria. Clinical for the treatment of various bacterial viruses caused by urinary, reproductive system, respiratory tract, digestive system, skin soft tissue, ear, nose, throat and eye infections.
Application&Function
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin

Applicable to the following infections caused by sensitive bacteria: 1. Urinary and reproductive system infections, including simple and complex urinary tract infections, bacterial prostatitis, Neisseria gonorrhoeae urethritis or cervicitis (including those caused by enzyme producing strains). 2. Respiratory infections, including Chemicalbook bronchial infections and lung infections caused by gram-negative bacilli. 3. Gastrointestinal infection caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc. 4. Typhoid fever. 5. Bone and joint infections. 6. Skin and soft tissue infection. 7. Systemic infections such as sepsis.

Specification
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials EnoxacinAPI CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials EnoxacinAPI CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials EnoxacinAPI CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin
API CAS 74011-58-8 Enoxacin Pharmaceutical Enoxacin Raw Materials Enoxacin

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier